VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Abiraterone and increased survival in metastatic prostate cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Abiraterone and increased survival in metastatic prostate cancer.
Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med. 2011 May 26; 364(21):1995-2005.
View in:
PubMed
subject areas
Aged
Androgen Antagonists
Androgens
Androstenes
Androstenols
Antineoplastic Combined Chemotherapy Protocols
Disease Progression
Double-Blind Method
Fatigue
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Neoplasm Metastasis
Prednisone
Prostatic Neoplasms
Steroid 17-alpha-Hydroxylase
Survival Analysis
Treatment Outcome
authors with profiles
CHRISTOPHER J LOGOTHETIS
ELENI EFSTATHIOU